Oftaquix Augndropar, lausn 5 mg/ml Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

oftaquix augndropar, lausn 5 mg/ml

santen oy* - levofloxacinum hemihýdrat - augndropar, lausn - 5 mg/ml

Oftaquix Augndropar, lausn í stakskammtaíláti 5 mg/ml Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

oftaquix augndropar, lausn í stakskammtaíláti 5 mg/ml

santen oy* - levofloxacinum hemihýdrat - augndropar, lausn í stakskammtaíláti - 5 mg/ml

Taflotan Augndropar, lausn í stakskammtaíláti 15 míkróg/ml Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

taflotan augndropar, lausn í stakskammtaíláti 15 míkróg/ml

santen oy* - tafluprostum inn - augndropar, lausn í stakskammtaíláti - 15 míkróg/ml

Pyrukynd Európai Unió - izlandi - EMA (European Medicines Agency)

pyrukynd

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

Crestor Filmuhúðuð tafla 5 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

crestor filmuhúðuð tafla 5 mg

astrazeneca a/s - rosuvastatinum kalsíum - filmuhúðuð tafla - 5 mg

Crestor Filmuhúðuð tafla 40 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

crestor filmuhúðuð tafla 40 mg

astrazeneca a/s - rosuvastatinum kalsíum - filmuhúðuð tafla - 40 mg